Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China flag China · Delayed Price · Currency is CNY
72.61
+0.61 (0.85%)
At close: Sep 18, 2026

SHA:688198 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
68.3939.7256.01295.31128.3156.78
Short-Term Investments
294.9270.97135.87133.32--
Trading Asset Securities
24.49283.83178.16107484.61615.53
Cash & Short-Term Investments
387.78594.52370.04535.62612.91772.31
Cash Growth
24.19%60.66%-30.91%-12.61%-20.64%1.36%
Accounts Receivable
190.86214.99133.448659.6140.39
Other Receivables
4.842.564.773.141.980.74
Receivables
195.7217.55138.2189.1461.5941.13
Inventory
92.2568.6252.7434.931.4921.96
Prepaid Expenses
15.350.04-1.6-0.28
Other Current Assets
33.052329.8217.9618.3917.51
Total Current Assets
724.13903.75590.81679.22724.37853.19
Property, Plant & Equipment
503.97479.36433.74278.28192.0989.85
Long-Term Investments
-20.6122.92182.48170.636.07
Goodwill
16.3616.8917.2717.01--
Other Intangible Assets
156.88161.54112.1892.7644.9643.16
Long-Term Deferred Tax Assets
17.3317.3814.8124.1628.6434.49
Long-Term Deferred Charges
13.4415.0318.880.931.461.99
Other Long-Term Assets
26.68.5120.2452.1717.772.2
Total Assets
1,4591,6231,4311,3271,1801,031

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.322.41.21.190.430.76
Accrued Expenses
48.7874.0950.9829.7924.8317.05
Short-Term Debt
4175----
Current Portion of Leases
3.173.193.453.270.840.94
Current Income Taxes Payable
0.0314.220.96-0.17-
Current Unearned Revenue
13.2414.621.320.460.430.62
Other Current Liabilities
28.2343.8556.3845.8836.5617.24
Total Current Liabilities
135.78227.37114.2880.5863.2636.6
Long-Term Leases
15.0615.436.339.020.560.72
Long-Term Unearned Revenue
37.1836.733.2333.4611.720.2
Long-Term Deferred Tax Liabilities
11.813.0513.0112.391.190.16
Other Long-Term Liabilities
20.517.2813.413.013.765.05
Total Liabilities
220.32309.83180.28138.4780.4942.73

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
137.75137.75137.4136.58135.6796.44
Additional Paid-In Capital
814.7813.63823.05803.27759.67733.85
Retained Earnings
307.81374.12290.47253.4206.03159.16
Comprehensive Income & Other
1.361.421.681.360.070.06
Total Common Equity
1,2541,3271,2531,1951,101989.51
Minority Interest
-15.35-13.72-2.03-6.06-2.02-1.28
Shareholders' Equity
1,2381,3131,2511,1891,099988.23
Total Liabilities & Equity
1,4591,6231,4311,3271,1801,031

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
59.2393.629.7912.291.41.66
Net Cash (Debt)
328.55500.91360.26523.33611.51770.65
Net Cash Growth
40.14%39.04%-31.16%-14.42%-20.65%1.15%
Net Cash Per Share
2.393.652.633.824.505.72
Filing Date Shares Outstanding
137.75137.75137.4136.58135.67135.01
Total Common Shares Outstanding
137.75137.75137.4136.58135.67135.01
Working Capital
588.35676.38476.52598.64661.12816.59
Book Value Per Share
9.109.639.128.758.127.33
Tangible Book Value
1,0801,1491,1231,0851,056946.35
Tangible Book Value Per Share
7.848.348.177.947.797.01
Buildings
269.54269.54254.9942.8842.8842.88
Machinery
173.57167.77135.9275.2841.3228.71
Construction In Progress
140.21105.4187.67190.24141.1547